Brief: Cortexyme Announces Change In Executive Leadership Team
Feb 1 (Reuters) - Cortexyme Inc CRTX.O :
* CORTEXYME ANNOUNCES CHANGE IN EXECUTIVE LEADERSHIP TEAM
Source text for Eikon: ID:nBw9Cylmra
Further company coverage: CRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges